Teriparatide improves alveolar bone modelling after tooth extraction in orchiectomized rats

Area of Science:

• Bone biology and regeneration
• Endocrinology and metabolism
• Oral and maxillofacial surgery

Background:

• Orchiectomy in male rats leads to altered bone metabolism, impacting alveolar bone repair.
• Teriparatide is a parathyroid hormone analog known for its bone-anabolic effects.
• Understanding teriparatide's role in alveolar bone regeneration is crucial for potential therapeutic applications.

Purpose of the Study:

• To investigate the effects of teriparatide on bone metabolism during alveolar repair in orchiectomized rats.
• To evaluate the expression of RANK-L and osteoprotegerin (OPG) in response to teriparatide treatment.
• To assess changes in bone volume, quality, and turnover post-tooth extraction.

Main Methods:

• Histological analysis, Real Time PCR, and immunohistochemistry were employed.
• Gene expression of RANK-L and OPG was quantified at 14 and 42 days.
• Microtomographic analysis assessed bone volume and quality, with calcein and alizarin labeling for bone turnover.

Main Results:

• Teriparatide increased RANK-L and OPG gene expression at 14 days, with a subsequent decrease in RANK-L and increase in OPG at 42 days.
• Significant increases in bone area, mineral deposition, and bone volume were observed in the teriparatide-treated group.
• Immunolabeling indicated enhanced remodeling and bone formation driven by the RANK-L/OPG ratio.

Conclusions:

• Teriparatide treatment effectively promotes alveolar bone repair in orchiectomized rats.
• The drug increases bone volume and reduces porosity, facilitating bone turnover.
• These findings highlight teriparatide's potential in managing bone defects in similar physiological conditions.